- Home
- CMMB vs GV Comparison
CMMB vs GV Comparison
Compare CMMB & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- GV
- Stock Information
- Founded
- CMMB 2004
- GV 2013
- Country
- CMMB Israel
- GV Canada
- Employees
- CMMB N/A
- GV N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- GV Other Consumer Services
- Sector
- CMMB Health Care
- GV Real Estate
- Exchange
- CMMB Nasdaq
- GV Nasdaq
- Market Cap
- CMMB 15.8M
- GV 14.7M
- IPO Year
- CMMB N/A
- GV 2022
- Fundamental
- Price
- CMMB $1.47
- GV $2.07
- Analyst Decision
- CMMB Strong Buy
- GV
- Analyst Count
- CMMB 3
- GV 0
- Target Price
- CMMB $5.67
- GV N/A
- AVG Volume (30 Days)
- CMMB 206.1K
- GV 2.5M
- Earning Date
- CMMB 11-07-2024
- GV 10-18-2024
- Dividend Yield
- CMMB N/A
- GV N/A
- EPS Growth
- CMMB N/A
- GV N/A
- EPS
- CMMB N/A
- GV 0.32
- Revenue
- CMMB N/A
- GV $9,380,985.00
- Revenue This Year
- CMMB N/A
- GV N/A
- Revenue Next Year
- CMMB N/A
- GV N/A
- P/E Ratio
- CMMB N/A
- GV $6.66
- Revenue Growth
- CMMB N/A
- GV 11.25
- 52 Week Low
- CMMB $0.42
- GV $1.52
- 52 Week High
- CMMB $2.55
- GV $8.85
- Technical
- Relative Strength Index (RSI)
- CMMB 43.82
- GV 42.35
- Support Level
- CMMB $1.46
- GV $2.03
- Resistance Level
- CMMB $1.58
- GV $2.64
- Average True Range (ATR)
- CMMB 0.15
- GV 0.26
- MACD
- CMMB -0.04
- GV -0.09
- Stochastic Oscillator
- CMMB 40.71
- GV 6.64
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.